Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.4K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

4.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.0K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

73
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
73

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered brain ion gradients following compensation for elevated CO2 are linked to behavioural alterations in a coral reef fish.

Scientific reports·2016
Same author

Boxing Injuries From an Instructional Program.

The Physician and sportsmedicine·2016
Same author

Women in the Military Academies: US Army (Part 3 of 3).

The Physician and sportsmedicine·2016
Same author

Workshop on the production, application and clinical translation of ''non-standard'' PET nuclides: a meeting report.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2007
Same author

Production of non-standard PET radionuclides and the application of radiopharmaceuticals labeled with these nuclides.

Ernst Schering Research Foundation workshop·2006
Same author

Pill swallowing ability and training in children 6 to 11 years of age.

Clinical pediatrics·2006
Same journal

Corrigendum.

The Journal of allergy and clinical immunology·2026
Same journal

Comparative Efficacy of Biologic Agents for Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Network Meta-analysis.

The Journal of allergy and clinical immunology·2026
Same journal

Tamoxifen-driven neutrophil reprogramming protects from pulmonary Granulibacter bethesdensis infection in chronic granulomatous disease.

The Journal of allergy and clinical immunology·2026
Same journal

Clinical and transcriptomic characterization of mixed granulocytic COPD phenotype.

The Journal of allergy and clinical immunology·2026
Same journal

Dupilumab outcomes in pediatric asthma by early eosinophil status: post hoc analysis of VOYAGE/EXCURSION.

The Journal of allergy and clinical immunology·2026
Same journal

Maternal antibiotic exposure alters the newborn metabolomic profile and increases the risk of respiratory infections in offspring: a 13-year longitudinal birth cohort study.

The Journal of allergy and clinical immunology·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 5, 2010

34.4K

Challenges in evaluating controller asthma therapy in children.

M J Welch1

  • 1Allergy and Asthma Medical Group and Research Center in San Diego, CA 92123, USA.

The Journal of Allergy and Clinical Immunology
|September 13, 2000
PubMed
Summary
This summary is machine-generated.

Limited clinical data exists for pediatric controller medications. More research is crucial to ensure safe and effective treatments for children, despite challenges in pediatric clinical studies.

More Related Videos

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.2K
Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges
08:22

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges

Published on: February 25, 2016

14.4K

Related Experiment Videos

Last Updated: May 6, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 5, 2010

34.4K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.2K
Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges
08:22

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges

Published on: February 25, 2016

14.4K

Area of Science:

  • Pediatric pharmacology and clinical trial research.

Background:

  • Efficacy and safety data for controller medications in pediatric patients are scarce compared to adults.
  • Pharmacological profiles in children may differ significantly from adults, necessitating pediatric-specific research.
  • Physicians require robust clinical evidence to confidently prescribe controller therapies for pediatric conditions.

Purpose of the Study:

  • To highlight the critical need for expanded clinical research on controller medications in pediatric populations.
  • To emphasize the importance of generating age-specific efficacy and safety data for pediatric patients.
  • To underscore the necessity of confirming adult medication data in children due to potential pharmacokinetic and pharmacodynamic differences.

Main Methods:

  • Review of existing clinical data limitations for pediatric controller medications.
  • Identification of the need for pediatric-inclusive clinical research studies.
  • Acknowledgement of challenges faced by pharmaceutical companies and investigators in pediatric drug research.

Main Results:

  • Current clinical data on controller medications is insufficient for pediatric patients of all ages.
  • Significant gaps exist in understanding the efficacy and safety profiles of these medications in children.
  • Existing adult data cannot be directly extrapolated to pediatric populations due to developmental differences.

Conclusions:

  • Clinical research must actively include pediatric populations to build a reliable evidence base for controller medications.
  • Overcoming challenges in pediatric clinical studies is essential for advancing treatment options for children.
  • Generating pediatric-specific data is paramount for informed clinical decision-making in pediatric pharmacotherapy.